Clover Health Investments Corp
NASDAQ:CLOV
Intrinsic Value
Clover Health Investments Corp. provides healthcare insurance services. [ Read More ]
The intrinsic value of one
CLOV
stock under the Base Case scenario is
2.0037
USD.
Compared to the current market price of 0.6356 USD,
Clover Health Investments Corp
is
Undervalued by 68%.
CLOV's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
CLOV or that its price is influenced by factors unrelated to fundamentals.
Clover Health Investments Corp's market capitalization is 310.8m USD.
CLOV stock price is 0.6356 USD.
CLOV stock price (0.6356 USD) is 68% less than its Intrinsic Value (2.0037 USD).
CLOV. Open DCF Valuation
CLOV stock price (0.6356 USD) is 68% less than its Relative Value (2.0037 USD). Open Relative Valuation
CLOV has upside potential of 131% compared to the average analyst price target.
Open Wall St Estimates
CLOV's Revenue is forecast to fall at a rate of 11% per year over the next 3 years.
CLOV's short-term assets (428m USD) exceed its short-term liabilties (261m USD).
CLOV's Revenue has dropped by 42% over the past 12 months.
CLOV's ROE (Return on Equity) has significantly decreased in the last 3 years from -9% to -66%, and is approaching profitability.
CLOV's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from -153% to -63%, and is approaching profitability.
CLOV's long-term assets (571m USD) exceed its long-term liabilties (284m USD).
CLOV has negative Operating Income for the last twelve months.
CLOV has negative Net Income for the last twelve months.
CLOV's ROE (Return on Equity) for the past 12 months is negative and is equal to -66%.
CLOV's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -63%.
CLOV has negative Free Cash Flow for the last twelve months.
CLOV has negative three-year average ROE (Return on Equity): -71%. The company is not efficient at transforming stockholders' equity into net income.
CLOV has negative three-year average ROIC (Return on Invested Capital): -63%. The company is not efficient at using invested capital to generate operating income.
CLOV's D/E (Debt to Equity) is very low and is equal to 0.
CLOV's Altman Z-Score is very low and is equal to -2.08.
Valuation Backtest
Clover Health Investments Corp
Run backtest to discover the historical profit from buying and selling
CLOV
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Clover Health Investments Corp
Balance Sheet Decomposition
Clover Health Investments Corp
| Current Assets | 428m |
| Cash & Short-Term Investments | 298.3m |
| Receivables | 91.8m |
| Other Current Assets | 37.9m |
| Non-Current Assets | 142.7m |
| Long-Term Investments | 121m |
| PP&E | 8.5m |
| Intangibles | 3m |
| Other Non-Current Assets | 10.2m |
| Current Liabilities | 261.1m |
| Accounts Payable | 37.2m |
| Accrued Liabilities | 22.7m |
| Other Current Liabilities | 201.2m |
| Non-Current Liabilities | 23.2m |
| Other Non-Current Liabilities | 23.2m |
Earnings Waterfall
Clover Health Investments Corp
|
Revenue
|
2B
USD
|
|
Operating Expenses
|
-2.2B
USD
|
|
Operating Income
|
-182.7m
USD
|
|
Other Expenses
|
-30.7m
USD
|
|
Net Income
|
-213.4m
USD
|
Free Cash Flow Analysis
Clover Health Investments Corp
What is Free Cash Flow?
CLOV Profitability Score
Profitability Due Diligence
Clover Health Investments Corp's profitability score is 16/100. The higher the profitability score, the more profitable the company is.
Score
Clover Health Investments Corp's profitability score is 16/100. The higher the profitability score, the more profitable the company is.
CLOV Solvency Score
Solvency Due Diligence
Clover Health Investments Corp's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Clover Health Investments Corp's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CLOV Price Targets Summary
Clover Health Investments Corp
According to Wall Street analysts, the average 1-year price target for
CLOV
is 1.4663 USD
with a low forecast of 1.01 USD and a high forecast of 2.1 USD.
Ownership
CLOV Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
CLOV Price
Clover Health Investments Corp
| Average Annual Return | -32.52% |
| Standard Deviation of Annual Returns | 74.11% |
| Max Drawdown | -97% |
| Market Capitalization | 310.8m USD |
| Shares Outstanding | 495 290 000 |
| Percentage of Shares Shorted | 10.91% |
CLOV News
Last Important Events
Clover Health Investments Corp
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Clover Health Investments Corp
Company Profile
Clover Health Investments Corp
Country
Industry
Market Cap
Dividend Yield
Description
Clover Health Investments Corp. provides healthcare insurance services. The company is headquartered in Franklin, Tennessee and currently employs 680 full-time employees. The company went IPO on 2020-06-12. The Company’s segments include Medicare Advantage (MA) and Direct Contracting (DC). The MA segment is an insurance business model that focuses on leveraging the Clover Assistant at the point of care. The Company’s DC segment is similar to the cost management and care coordination model accounted for as a performance guarantee, where Clover is responsible for coordinating care, managing costs, and providing support to providers and their direct contracting entity (DCE) beneficiaries through the use of Clover Assistant. The company offers a software platform called the Clover Assistant, which provides America’s seniors with Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans that are the obvious choice for Medicare-eligible consumers. The Clover Assistant is a technology platform that engages providers and delivers data-driven and personalized care. The company operates its MA plans in over nine states.
Contact
IPO
Employees
Officers
The intrinsic value of one
CLOV
stock under the Base Case scenario is
2.0037
USD.
Compared to the current market price of 0.6356 USD,
Clover Health Investments Corp
is
Undervalued by 68%.
You don't have any saved screeners yet
